CHI3L1
Chitinase-3-like protein 1
Also known as: CH3L1_HUMAN, GP39, YK-40, YKL40
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P36222
- Gene
- CHI3L1
- Ensembl
- ENSG00000133048
- Chromosome
- 1
- Canonical length
- 383 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus,Vesicles
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Chitinases catalyze the hydrolysis of chitin, which is an abundant glycopolymer found in insect exoskeletons and fungal cell walls. The glycoside hydrolase 18 family of chitinases includes eight human family members. This gene encodes a glycoprotein member of the glycosyl hydrolase 18 family. The protein lacks chitinase activity and is secreted by activated macrophages, chondrocytes, neutrophils and synovial cells. The protein is thought to play a role in the process of inflammation and tissue remodeling. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
383 residues, UniProt reviewed canonical sequence.
>P36222|CHI3L1
1 MGVKASQTGF VVLVLLQCCS AYKLVCYYTS WSQYREGDGS CFPDALDRFL CTHIIYSFAN
61 ISNDHIDTWE WNDVTLYGML NTLKNRNPNL KTLLSVGGWN FGSQRFSKIA SNTQSRRTFI
121 KSVPPFLRTH GFDGLDLAWL YPGRRDKQHF TTLIKEMKAE FIKEAQPGKK QLLLSAALSA
181 GKVTIDSSYD IAKISQHLDF ISIMTYDFHG AWRGTTGHHS PLFRGQEDAS PDRFSNTDYA
241 VGYMLRLGAP ASKLVMGIPT FGRSFTLASS ETGVGAPISG PGIPGRFTKE AGTLAYYEIC
301 DFLRGATVHR ILGQQVPYAT KGNQWVGYDD QESVKSKVQY LKDRQLAGAM VWALDLDDFQ
361 GSFCGQDLRF PLTNAIKDAL AATLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHI3L1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 424 nTPM
Expression across tissuesHPA
Tissue
- liver: 424 nTPM
- choroid plexus: 348 nTPM
- bone marrow: 220 nTPM
- midbrain: 181 nTPM
- basal ganglia: 168 nTPM
- cerebral cortex: 154 nTPM
Single-cell type
- endometrial secretory cells: 203 nCPM
- neutrophil progenitors: 161 nCPM
- podocytes: 153 nCPM
- breast secretory cells: 128 nCPM
- alveolar cells type 2: 106 nCPM
- decidual stromal cells: 96 nCPM
Immune cell
- neutrophil: 472 nTPM
- total PBMC: 1.3 nTPM
- non-classical monocyte: 0.9 nTPM
- eosinophil: 0.7 nTPM
- classical monocyte: 0.4 nTPM
- intermediate monocyte: 0.1 nTPM
Brain region
- medulla oblongata: 429 nTPM
- thalamus: 269 nTPM
- pons: 216 nTPM
- hypothalamus: 205 nTPM
- midbrain: 166 nTPM
- cerebral cortex: 88 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CHI3L1.
Disease | AllUniProt
Conditions CHI3L1 is implicated in, by any mechanism.
- Asthma-related traits 7 (ASRT7) MIM:611960
- Schizophrenia (SCZD) MIM:181500
Disease | ImmuneIEDB
Conditions an epitope on CHI3L1 was assayed in.
- rheumatoid arthritis T cell
ReferencesPubMed · IEDB
Publications for CHI3L1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Autoantibody testing by enzyme-linked immunosorbent assay-a case in which the solid phase decides on success and failure.
2020 · Heliyon · RCR 0.8 · 12 citations - Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies.
2023 · World J Gastroenterol · RCR 0.5 · 4 citations - Elevated plasma YKL-40 level is found in the dogs with cancer and is related to poor prognosis.
2019 · J Vet Sci · RCR 0.3 · 3 citations - Chitinase 3-like 1 is not a target antigen in patients with multiple sclerosis.
2021 · Mult Scler · RCR 0.2 · 3 citations - Circulating CHI3L1 autoantibodies serve as a diagnostic biomarker in patients with obstructive sleep apnea.
2025 · Sci Rep · 4 citations
Reference: T cellIEDB
3 publications
- Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis.
1997 · Arthritis Rheum · RCR 3.8 · 167 citations - T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles.
1999 · Arthritis Rheum · RCR 1.8 · 89 citations - Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions.
2000 · Rheumatology (Oxford) · RCR 0.9 · 40 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.58
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of NF-kappaB-inducing kinase activity
- apoptotic process
- carbohydrate metabolic process
- cartilage development
- cellular response to tumor necrosis factor
- chitin catabolic process
- inflammatory response
- lung development
- positive regulation of angiogenesis
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of interleukin-8 production
- positive regulation of peptidyl-threonine phosphorylation
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- response to interleukin-1
- response to interleukin-6
- response to mechanical stimulus
- response to tumor necrosis factor
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHI3L1 as an antibody target. Whether an autoantibody or antibody against CHI3L1 could matter depends on whether native CHI3L1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHI3L1 is annotated as secreted, so native CHI3L1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CHI3L1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...